Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Solid Biosciences Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −22 vs. Q3 2022
- Shares held
- 15.3M
- −48.2M (−75.9%) vs. Q3 2022
- Total value
- $85.6M
- +$52.2M (+156.4%) vs. Q3 2022
- New holders
- 7
- 0 more added
- Sold out
- 29
- 28 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $718.9M |
| Q4 2025 | 132 | $459.3M |
| Q3 2025 | 129 | $505.4M |
| Q2 2025 | 116 | $405.3M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.9M |
| Q2 2024 | 80 | $213.3M |
| Q1 2024 | 56 | $467.4M |
| Q4 2023 | 40 | $102.3M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $156.1M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $342.5M |
| Q1 2021 | 104 | $437.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 3,495,933 | $18.8M | 0.54% | −9,916,619−73.9% | Reduced |
| Ra Capital Management, L.P. | 3,426,286 | $18.4M | 0.37% | −8,941,587−72.3% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 3,130,422 | $16.8M | 1.88% | −4,799,496−60.5% | Reduced |
| Camber Capital Management LP | 1,418,439 | $7.63M | 0.27% | +1,418,439 | New |
| Laurion Capital Management LP | 928,169 | $4.99M | 0.14% | −228,431−19.8% | Reduced |
| Artal Group S.A. | 909,219 | $4.89M | 0.28% | −2,090,781−69.7% | Reduced |
| Caas Capital Management LP | 283,687 | $4.81M | 0.93% | +283,687 | New |
| Alyeska Investment Group, L.P. | 540,147 | $2.89M | 0.03% | −7,562,076−93.3% | Reduced |
| K2 Principal Fund, L.P. | 342,271 | $1.84M | 0.50% | −5,218,965−93.8% | Reduced |
| Vanguard Group Inc | 222,697 | $1.20M | 0.00% | −3,116,459−93.3% | Reduced |
| Finepoint Capital LP | 218,562 | $1.18M | 0.38% | +218,562 | New |
| BlackRock Inc. | 144,064 | $775.1K | 0.00% | −2,693,835−94.9% | Reduced |
| Dimensional Fund Advisors LP | 55,738 | $300.0K | 0.00% | +55,738 | New |
| Renaissance Technologies LLC | 51,763 | $278.0K | 0.00% | −960,507−94.9% | Reduced |
| Geode Capital Management, LLC | 39,081 | $210.0K | 0.00% | −591,288−93.8% | Reduced |
| State Street Corp | 22,647 | $121.8K | 0.00% | −317,095−93.3% | Reduced |
| Bridgeway Capital Management, LLC | 19,686 | $105.9K | 0.00% | −275,614−93.3% | Reduced |
| Millennium Management LLC | 12,846 | $69.0K | 0.00% | −303,896−95.9% | Reduced |
| Tower Research Capital LLC (TRC) | 11,851 | $64.0K | 0.00% | −12,836−52.0% | Reduced |
| Old Well Partners, LLC | 10,800 | $58.1K | 0.05% | +10,800 | New |
| Acadian Asset Management LLC | 9,507 | $50.0K | 0.00% | −109,886−92.0% | Reduced |
| Morgan Stanley | 4,687 | $25.2K | 0.00% | −96,217−95.4% | Reduced |
| Barclays PLC | 4,437 | $23.9K | 0.00% | −62,127−93.3% | Reduced |
| Bank of America Corp | 2,723 | $14.6K | 0.00% | −32,267−92.2% | Reduced |
| Belpointe Asset Management LLC | 1,367 | $7.35K | 0.00% | +1,367 | New |
| Manchester Capital Management LLC | 1,000 | $5.38K | 0.00% | +1,000 | New |
| Royal Bank of Canada | 324 | $2.00K | 0.00% | −3,254−90.9% | Reduced |
| Group One Trading, L.P. | 287 | $1.54K | 0.00% | −16,368−98.3% | Reduced |
| JPMorgan Chase & Co | 133 | $1.00K | 0.00% | −6,276−97.9% | Reduced |
| UBS Group AG | 166 | $893 | 0.00% | −2,334−93.4% | Reduced |
| First Manhattan Co | 133 | $715 | 0.00% | −2,267−94.5% | Reduced |
| Wells Fargo & Company | 94 | $506 | 0.00% | −1,311−93.3% | Reduced |
| Investors Research Corp | 13 | $70 | 0.00% | −587−97.8% | Reduced |
| Parallel Advisors, LLC | 6 | $32 | 0.00% | −94−94.0% | Reduced |
| Advisor Group Holdings, Inc. | 30 | $0 | 0.00% | −435−93.5% | Reduced |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −204,263−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −187,100−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −156,900−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −145,678−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −140,062−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −113,496−100.0% | Sold out |
| Highland Private Wealth Management | 0 | $0 | 0.00% | −89,340−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −56,471−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −52,144−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −46,200−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −40,502−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −45,856−100.0% | Sold out |
| Quantum Private Wealth, LLC | 0 | $0 | 0.00% | −40,371−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −29,731−100.0% | Sold out |
| IPG Investment Advisors LLC | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,181−100.0% | Sold out |
| Newman Dignan & Sheerar, Inc. | 0 | $0 | 0.00% | −15,023−100.0% | Sold out |
| Tranquility Partners, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −10,812−100.0% | Sold out |
| Running Point Capital Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −3,088−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,470−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −1,394−100.0% | Sold out |
| Global Trust Asset Management, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −1,059−100.0% | Sold out |
| Corsicana & Co. | – | – | – | – | Not filed |